Neurocrine Biosciences (NBIX) Tax Provisions (2019 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Tax Provisions of $17.8 million for Q2 2026, down 65.77% year-over-year from $52.0 million in Q2 2025, and down 63.6% on a QoQ basis from $48.9 million in Q1 2026.
Neurocrine Biosciences (NBIX) Tax Provisions (2019 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Tax Provisions for 8 years, with the latest figure at $17.8 million in Q2 2026.
- Tax Provisions for Q2 2026 came in at $17.8 million, down 65.77% year-over-year; the trailing twelve-month figure through Jun 2026 was $234.7 million (up 31.26% YoY), and the FY2025 annual result was $226.8 million, up 56.74% from the prior year.
- Tax Provisions eased to $17.8 million in Q2 2026, from $48.9 million in the prior quarter.
- Over five years, Tax Provisions peaked at $85.7 million in Q4 2025 and troughed at -$26.7 million in Q1 2023.
- A 5-year average of $32.2 million and a median of $31.0 million in 2022 frame the typical range for Tax Provisions.
- The widest annual swing landed in 2023, when Tax Provisions sank 456.0%; it then jumped 619.12% in 2026.
- A 5-year view of Tax Provisions shows it stood at $28.9 million in 2022, then soared by 74.74% to $50.5 million in 2023, then grew by 17.82% to $59.5 million in 2024, then jumped by 44.03% to $85.7 million in 2025, then tumbled by 79.23% to $17.8 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $17.8 million in Q2 2026, $48.9 million in Q1 2026, and $85.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.80 Mn |
| Mar 31, 2026 | 48.90 Mn |
| Dec 31, 2025 | 85.70 Mn |
| Sep 30, 2025 | 82.30 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 59.50 Mn |
| Sep 30, 2024 | 60.50 Mn |
| Jun 30, 2024 | 33.60 Mn |
| Mar 31, 2024 | -8.90 Mn |
| Dec 31, 2023 | 50.50 Mn |
| Sep 30, 2023 | 32.50 Mn |
| Jun 30, 2023 | 26.10 Mn |
| Mar 31, 2023 | -26.70 Mn |
| Dec 31, 2022 | 28.90 Mn |
| Sep 30, 2022 | 29.40 Mn |
| Jun 30, 2022 | -6.40 Mn |
| Mar 31, 2022 | 7.50 Mn |
| Dec 31, 2021 | -6.50 Mn |
| Sep 30, 2021 | 8.00 Mn |